| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The Journal of Immunology, Vol 155, Issue 6 3205-3212, Copyright © 1995 by American Association of Immunologists
ARTICLES |
H Dang, AG Geiser, JJ Letterio, T Nakabayashi, L Kong, G Fernandes and N Talal
Audie L. Murphy Memorial Veterans Hospital, San Antonio, Texas, USA.
Mice bearing the TGF-beta 1 null mutation (-/-) develop lymphoid infiltrates in the heart, lungs, salivary glands, and other organs similar to those seen in the pseudolymphoma of Sjogren's Syndrome. We studied sera from -/- mice and found elevated Ab levels to dsDNA, ssDNA, and Sm ribonucleoprotein. No Abs to SSA/Ro or SSB/La and no IgM rheumatoid factor were found. Serum autoantibodies were predominately IgG and were specific as shown by ELISA inhibition studies. Antinuclear Ab patterns on Western blots varied from one mouse to the next, indicating a random process responsible for the diversity. Wild-type and heterozygote mice had no autoantibodies. Ig glomerular deposits were found in -/- mice, indicating that these autoantibodies may be pathogenic. Treatment of -/- mice with dexamethasone or TGF-beta 1 failed to suppress autoantibody production. These mice represent an overlap combining the autoimmune serology of SLE with the tissue infiltrates of SS. Our results support the concept that TGF-beta 1 is an important naturally occurring immunosuppressive cytokine whose absence can lead to a systemic autoimmune disease.
This article has been cited by other articles:
|
|
 |
|
  V. Saxena, D. W. Lienesch, M. Zhou, R. Bommireddy, M. Azhar, T. Doetschman, and R. R. Singh Dual Roles of Immunoregulatory Cytokine TGF-{beta} in the Pathogenesis of Autoimmunity-Mediated Organ Damage J. Immunol., February 1, 2008; 180(3): 1903 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.S. Prime, M. Pring, M. Davies, and I.C. Paterson TGF-{beta} SIGNAL TRANSDUCTION IN ORO-FACIAL HEALTH AND NON-MALIGNANT DISEASE (PART I) Critical Reviews in Oral Biology & Medicine, November 1, 2004; 15(6): 324 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mamura, W. Lee, T. J. Sullivan, A. Felici, A. L. Sowers, J. P. Allison, and J. J. Letterio CD28 disruption exacerbates inflammation in Tgf-{beta}1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-{beta}1 Blood, June 15, 2004; 103(12): 4594 - 4601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rosendahl, M. Speletas, K. Leandersson, F. Ivars, and P. Sideras Transforming growth factor-{beta}- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis Int. Immunol., December 1, 2003; 15(12): 1401 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-m. Chen, M. J. O'Shaughnessy, I. Gramaglia, A. Panoskaltsis-Mortari, W. J. Murphy, S. Narula, M. G. Roncarolo, and B. R. Blazar IL-10 and TGF-{beta} induce alloreactive CD4+CD25- T cells to acquire regulatory cell function Blood, June 15, 2003; 101(12): 5076 - 5083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Thyagarajan, S. Totey, M. J. S. Danton, and A. B. Kulkarni GENETICALLY ALTERED MOUSE MODELS: THE GOOD, THE BAD, AND THE UGLY Critical Reviews in Oral Biology & Medicine, May 1, 2003; 14(3): 154 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Schotte, P Willeke, S Rust, G Assmann, W Domschke, M Gaubitz, and B Schluter The transforming growth factor-{beta}1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus Lupus, February 1, 2003; 12(2): 86 - 92. [Abstract] [PDF]
|
|
|
|
 |
|
 K. C. Flanders and J. K. Burmester Medical Applications of Transforming Growth Factor-{beta} Clin. Med. Res., January 1, 2003; 1(1): 13 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Lawman and M R Ehrenstein Many paths lead to lupus Lupus, December 1, 2002; 11(12): 801 - 806. [PDF]
|
|
|
|
 |
|
 J. Cheng and J. P. Grande Transforming Growth Factor-{beta} Signal Transduction and Progressive Renal Disease Experimental Biology and Medicine, December 1, 2002; 227(11): 943 - 956. [Abstract] [Full Text]
|
|
|
|
|
|
N. L. McCartney-Francis and S. M. Wahl Dysregulation of IFN-{gamma} Signaling Pathways in the Absence of TGF-{beta}1 J. Immunol., November 15, 2002; 169(10): 5941 - 5947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Piccirillo, J. J. Letterio, A. M. Thornton, R. S. McHugh, M. Mamura, H. Mizuhara, and E. M. Shevach CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor {beta}1 Production and Responsiveness J. Exp. Med., July 15, 2002; 196(2): 237 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.B. Sugerman, N.W. Savage, L.J. Walsh, Z.Z. Zhao, X.J. Zhou, A. Khan, G.J. Seymour, and M. Bigby THE PATHOGENESIS OF ORAL LICHEN PLANUS Critical Reviews in Oral Biology & Medicine, July 1, 2002; 13(4): 350 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Davidson and B. Diamond Autoimmune Diseases N. Engl. J. Med., August 2, 2001; 345(5): 340 - 350. [Full Text] [PDF]
|
|
|
|
|
|
P. J. Lucas, S.-J. Kim, S. J. Melby, and R. E. Gress Disruption of T Cell Homeostasis in Mice Expressing a T Cell-specific Dominant Negative Transforming Growth Factor {beta} II Receptor J. Exp. Med., April 3, 2000; 191(7): 1187 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. D. Gresham, B. M. Dale, J. W. Potter, P. W. Chang, C. M. Vines, C. A. Lowell, C. F. Lagenaur, and C. L. Willman Negative Regulation of Phagocytosis in Murine Macrophages by the Src Kinase Family Member, Fgr J. Exp. Med., February 7, 2000; 191(3): 515 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Grainger, D. Mosedale, J. Metcalfe, and E. Bottinger Dietary fat and reduced levels of TGFbeta1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions J. Cell Sci., January 7, 2000; 113(13): 2355 - 2361. [Abstract] [PDF]
|
|
|
|
 |
|
 M. L. Stoll and J. Gavalchin Systemic lupus erythematosus--messages from experimental models Rheumatology, January 1, 2000; 39(1): 18 - 27. [Full Text] [PDF]
|
|
|
|
|
|
S. Kobayashi, K. Yoshida, J. M. Ward, J. J. Letterio, G. Longenecker, L. Yaswen, B. Mittleman, E. Mozes, A. B. Roberts, S. Karlsson, et al. {beta}2-Microglobulin-Deficient Background Ameliorates Lethal Phenotype of the TGF-{beta}1 Null Mouse J. Immunol., October 1, 1999; 163(7): 4013 - 4019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Brown, S. Patil, C. D. Cianci, J. S. Morrow, and P. H. Howe Transforming Growth Factor beta Induces Caspase 3-independent Cleavage of alpha II-Spectrin (alpha -Fodrin) Coincident with Apoptosis J. Biol. Chem., August 13, 1999; 274(33): 23256 - 23262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Mohan, Y. Yu, L. Morel, P. Yang, and E. K. Wakeland Genetic Dissection of Sle Pathogenesis: Sle3 on Murine Chromosome 7 Impacts T Cell Activation, Differentiation, and Cell Death J. Immunol., June 1, 1999; 162(11): 6492 - 6502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Datto, J. P. Frederick, L. Pan, A. J. Borton, Y. Zhuang, and X.-F. Wang Targeted Disruption of Smad3 Reveals an Essential Role in Transforming Growth Factor beta -Mediated Signal Transduction Mol. Cell. Biol., April 1, 1999; 19(4): 2495 - 2504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A N Theofilopoulos Effector and predisposing genes in murine lupus Lupus, November 1, 1998; 7(9): 575 - 584. [Abstract] [PDF]
|
|
|
|
|
|
J P Grande Mechanisms of progression of renal damage in lupus nephritis:Pathogenesis of renal scarring Lupus, November 1, 1998; 7(9): 604 - 610. [Abstract] [PDF]
|
|
|
|
|
|
K. Ohtsuka, J. D. Gray, M. M. Stimmler, B. Toro, and D. A. Horwitz Decreased Production of TGF-{beta} by Lymphocytes from Patients with Systemic Lupus Erythematosus J. Immunol., March 1, 1998; 160(5): 2539 - 2545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bridoux, A. Badou, A. Saoudi, I. Bernard, E. Druet, R. Pasquier, P. Druet, and L. Pelletier Transforming Growth Factor beta (TGF-beta )-dependent Inhibition of T Helper Cell 2 (Th2)-induced Autoimmunity by Self-Major Histocompatibility Complex (MHC) Class II-specific, Regulatory CD4+ T Cell Lines J. Exp. Med., May 19, 1997; 185(10): 1769 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Furukawa Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity Lupus, January 1, 1997; 6(2): 193 - 202. [PDF]
|
|
|
|
|
|
T. A. Borkowski, J. J. Letterio, A. G. Farr, and M. C. Udey A Role for Endogenous Transforming Growth Factor beta 1 in Langerhans Cell Biology: The Skin of Transforming Growth Factor beta 1 Null Mice Is Devoid of Epidermal Langerhans Cells J. Exp. Med., December 15, 1996; 184(6): 2417 - 2422. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
